Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination
4.9
$ 11.50
In stock
(72)
Product Description
Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population
BNT162b2 mRNA COVID-19 Vaccine: First Approval
Comparative effectiveness of the BNT162b2 and ChAdOx1 vaccines against Covid-19 in people over 50
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine - ScienceDirect
mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar
Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines
Effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes in Ontario, Canada: a test-negative design study
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera
Pfizer Covid vaccine is 95% effective, plans to submit to FDA in days
